|
authors:
|
Abstract: Aim: a case report of a 5-year experience of regional (arterial chemoembolization) treatment of a patient with isolated liver metastases of skin melanoma. Materials and Methods: in 1994, the patient performed excision of melanoma in the right scapular region. Patient didn't undergo another treatment. During examination in 2006 metastasis in the liver was revealed. Patient recieved five rounds of chemotherapy Aranoza, Temodal, Kanglite. Metastatic tumer, sized 16,5 х14,5 х18,5 cm, occupied right liver lobe with deformation of it. After gaining this data - patient received 2 courses of liver chemoembolization in 2008. Results: during the 5 years follow-up - progression of tumor lesion is not noticed. Conclusion: the optimal transarterial chemoembolization creates possibilities for an efficient delivery of drugs and tumor embolization particles in the affected organ, particularly in the liver. In addition to surgery (with resectable formations) and systemic chemotherapy, above capabilities regional transarterial therapy can provide long term as new palliative treatment of patients with metastatic melanoma. References 1. Davydov M.I., Axel E.M. Mortality in Russia and the CIS countries from cancer in 2009 [Mortality of population in Russian Federation and CIS from malignant neoplasms in 2009]. Vestnik RCRC im. N.N. Blokhin RAMS. 2011; 22(3) 1: 57 [In Russ]. 2. Tuomaala S., Eskelin S., Tarkkanen A., Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest. Ophthalmol. Vis Sci 43: 3399-3408, 2002. 3. Becker J.C., Terheyden P., Kampgen E., Wagner S., Neumann C., Schadendorf D., Steinmann A., Wittenberg G., Lieb W., BrockerE.B. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and inter-leukin 2. Br. J. Cancer 2002;87: 8400-845. 4. Bedikian A.Y, Legha S.S., Mavligit G., Carrasco C.H., Khorana S., Pager C., Papadopoulos N., Benjamin R.S. Treatment of uveal melanoma metastatic to the liver. Cancer 76: 1665-1670, 1995. 5. Aubin J.M., Rekman J., Vandenbroucke-Menu F., Lapointe R., Fairfull-Smith R.J., Mimeault R., Balaa F.K., Martel G. Systematic review and meta-analysis of liver resection for metastatic melanoma. Br. J. Surg. 2013 Aug;100(9):1138-47. doi: 10.1002/bjs.9189. Epub 2013 Jun 17. 6. Ramia J.M., Garcfa-Bracamonte B., de la Plaza R., Ortiz P., Garcfa-Parreno J., Vanaclocha F. Surgical treatment of melanoma liver metastases. Cir. Esp. 2013 Jan;91 (1 ):4-8. doi: 10.1016/j.ciresp.2012.10.002. Epub 2012 Dec 6. 7. Gragoudas E.S., Egan K.M., Seddon J.M., Glynn R.J., Walsh S.M., Finn S.M., Munzenrider J.E., Spar M.D. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 ; 98:383-389. 8. Agarwala S.S., Eggermont A.M., O'Day S., Zager J.S. Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer. 2013 Dec 2. doi: 10.1002/cncr.28480. 9. Pyrhonen S. The treatment of metastatic uveal melanoma. Eur. J. Cancer 34(Suppl 3): S27-30, 1998. 10. Mavligit G.M., Charnsangavej C., Carrasco C.H., Patt YZ., Benjamin R.S., Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA. 1988; 260:974 -976. 11. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8 : 425-437. 12. Ahrar J., Gupta S., Ensor J., Ahrar K., Madoff D.C., Wallace M.J., Murthy R., Tam A., Hwu P, Bedikian A.Y Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest. 2011 Jan;29(1 ):49-55. doi: 10.3109/07357907.2010.535052. 13. Brown R.E., Gibler K.M., Metzger T., Trofimov I., Krebs H., Romero F.D., Scoggins C.R., McMasters K.M., Martin R.C. 2nd. Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry. Am. Surg. 2011 Jan;77(1):93-8. 14. Sharma K.V., Gould J.E., Harbour J.W., Linette G.P., Pilgram T.K., Dayani PN., Brown D.B. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am. J. Roentgenol. 2008 Jan; 190(1): 99-104. 15. Patel K., Sullivan K., Berd D., Mastrangelo M.J., Shields C.L., Shields J.A., Sato T. Chemoembolization of hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 15(4): 297-304, 2005. 16. Vogl T., Eicheler K., Zangos S., Herzog C., Hammerstingl R., Balzer J., Gholami A. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J. Cancer Res. Clin. Oncol. 133: 177-184, 2007.
Abstract: Despite the comparatively low morbidity rate, skin melanoma is known for its high mortality rate. High metastatic potential of the tumor, urges the necessity of improving methods of diagnostics, which can identify metastasis and assess the degree of dissemination at the early stage of disease. We have analyzed results of ultrasound imaging of one of the earliest and frequent types of progression of melanoma - metastasis in regional lymphatic nodes. The article presents results of examination of 182 patients with skin melanoma with early metastasis in lymphatic nodes, also - characteristics of the image of tumor changes are described. The high informativeness of ultrasound research for timely identification of metastatic changes and, respectively, the increase of the rate of survival of patients with skin melanoma are demonstrated. References 1. American Cancer Society.: Cancer Facts and Figures 2012. [Электронный ресурс]//Atlanta, Ga: American Cancer Society, 2012. URL: http://www.cancer.org/Research/ CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2012 (дата обращения: 21.12.2012) 2. Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Atkins M.B., Byrd D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 2009; 27(36): 6199-6206. 3. College of American Pathologists (CAP). Protocol for the Examination of Specimens from Patients with Melanoma of the Skin [Электронный ресурс]//Version 3.2.0.0. June 2011. URL: http://www.cap.org/apps/ docs/committees/cancer/cancer_protocols/2012/ SkinMelanoma_12protocol.pdf (дата обращения: 2012.12.21) 4. Thompson J.F, Shaw H.M. Sentinel node mapping for melanoma: results of trials and current applications. Surg. Oncol Clin. N. Am. 2007;16(1): 35-54. 5. Ferrone C.R., Panageas K.S., Busam K. et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann. Surg. Oncol. 2002; 9(7): 637-645. 6. Gershenwald J.E., Mansfield P.F., Lee J.E. et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 7. O’Brien CJ., Uren R.F, Thompson J.F. et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am. J. Surg. 1995; 170(5): 461-466. 8. Uren R.F. Lymphatic drainage of the skin. Ann. Surg. Oncol. 2004; 11(3 Suppl): 179-185. 9. Blum A., Schlagenhauff B., Stroebel W. et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma. Cancer. 2000; 88 (11): 2534-2539. 10. Voit C.A., Van Akkooi A.C.J., Sc^fer-Hesterberg G. et al. Ultrasound Morphology Criteria Predict Metastatic Disease of the Sentinel Nodes in Patients With Melanoma. J. Clin. Oncology. 2010; 28 (5): 847-852. 11. Voit C.A., van Akkooi A.C.J., Schaefer-Hesterberg G. et al. Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration (FNAC) cytology: Can US-guided FNAC replace SN staging in patients with melanoma? J. Clin. Oncol. 2009; 27: 4994-5000. 12. Струков А.И., Серов В.В. Патологическая анатомия. 4-е изд. М.: Медицина, 1995. 688.
